comparemela.com

Page 28 - Cdsco News Today : Breaking News, Live Updates & Top Stories | Vimarsana

CDSCO approves HiMedia s latest COVID-19 testing products

The solutions encourage smaller laboratories that cannot afford high-end automation and reduces dependency on skilled technicians

Central drugs standard control organizationDrugs standard control organizationKit dry swabIgenomb himedia

Each Dose Of Covaxin, Covishield Likely To Be Capped At Rs 275 After Getting Regular Market Approval

Each Dose Of Covaxin, Covishield Likely To Be Capped At Rs 275 After Getting Regular Market Approval
swarajyamag.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from swarajyamag.com Daily Mail and Mail on Sunday newspapers.

New delhiV krishna mohanPrakash kumar singhNational pharmaceutical pricing authorityCentral drugs standard control organisation onExpert committeeSubject expert committeeCentral drugs standard control organisationKumar singhSerum institueDrugs controller generalBharat biotechEmergency use authorisationFull market authorisation

DC Edit | As 3rd wave picks pace, ensure citizens jabbed

India reported more than three lakh new cases on Thursday, the first time in the third wave, and close to 500 deaths

Uttar pradeshTamil naduSupreme courtIndian council for medical research balram bhargavaExpert committeeCentral drugs standard control organisationIndian councilMedical research balram bhargavaWest bengalPrime ministerSubject expert committeeCovid 19Indian council for medical researchBalram bhargavaUnion governmentSupreme court

Centre s Expert Panel Recommends Regular Market Approval for Covishield, Covaxin

The recommendations will now be sent to the DCGI for final approval.

New delhiV krishna mohanPrakash kumar singhBharat biotech international limitedExpert committeeSerum institute of indiaCentral drugs standard control organisationSerum instituteBharat biotechDrugs controller generalKumar singhHyderabad based bharat biotechBiotech international limitedEmergency use authorisationSubject expert committeeCdsco sec

SEC recommends Covaxin, Covishield for full market authorisation

The subject expert committee during the meeting that was held last week asked both the companies to submit more data before granting market approval.

Serum institute of indiaCentral drugs standard control organisationDrugs controller generalSerum instituteBharat biotechCovid 19 vaccinesSerum institute of indiaBharat biotech vaccines

vimarsana © 2020. All Rights Reserved.